Drug Delivery Stocks List

Recent Signals

Date Stock Signal Type
2020-01-21 CTTH NR7 Range Contraction
2020-01-21 CTTH Narrow Range Bar Range Contraction
2020-01-21 CTTH Bollinger Band Squeeze Range Contraction
2020-01-21 CURR 180 Bearish Setup Bearish Swing Setup
2020-01-21 CURR Doji - Bullish? Reversal
2020-01-21 GNBT Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-01-21 GNBT 20 DMA Support Bullish
2020-01-21 IGXT Fell Below 20 DMA Bearish
2020-01-21 INSYQ Calm After Storm Range Contraction
2020-01-21 INSYQ Crossed Above 50 DMA Bullish
2020-01-21 INSYQ Upper Bollinger Band Walk Strength
2020-01-21 INSYQ MACD Bullish Centerline Cross Bullish
2020-01-21 NDEKY Crossed Above 50 DMA Bullish
2020-01-21 NDEKY Bollinger Band Squeeze Range Contraction
2020-01-21 NDEKY MACD Bullish Signal Line Cross Bullish
2020-01-21 NNBR New 52 Week High Strength
2020-01-21 NNBR New 52 Week Closing High Bullish
2020-01-21 PRTT New 52 Week Closing Low Bearish
2020-01-21 PRTT Narrow Range Bar Range Contraction
2020-01-21 PRTT New 52 Week Low Weakness
2020-01-21 RYLPF New 52 Week Closing High Bullish
2020-01-21 RYLPF Expansion Breakout Bullish Swing Setup
2020-01-21 RYLPF Reversal New Highs Setup Bullish Swing Setup
2020-01-21 RYLPF Slingshot Bullish Bullish Swing Setup
2020-01-21 RYLPF Bollinger Band Squeeze Range Contraction
2020-01-21 RYLPF New 52 Week High Strength
2020-01-21 TGOPY Volume Surge Other
2020-01-21 TGOPY 50 DMA Support Bullish
2020-01-21 TGOPY 20 DMA Support Bullish
2020-01-21 TGOPY Pocket Pivot Bullish Swing Setup
2020-01-21 TPVG New 52 Week Closing Low Bearish
2020-01-21 TPVG Hot IPO Pullback Bullish Swing Setup
2020-01-21 TPVG New 52 Week Low Weakness
2020-01-21 TPVY Narrow Range Bar Range Contraction
2020-01-21 TPVY Hot IPO Pullback Bullish Swing Setup
2020-01-21 TTNPW New 52 Week High Strength
2020-01-21 TTNPW Calm After Storm Range Contraction
2020-01-21 TTNPW New 52 Week Closing High Bullish
2020-01-21 TTNPW Pocket Pivot Bullish Swing Setup
2020-01-21 WST New 52 Week Closing High Bullish
2020-01-21 WST New 52 Week High Strength

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. Drug release is from: diffusion, degradation, swelling, and affinity-based mechanisms. Some of the common routes of administration include the enteral (gastrointestinal tract), parenteral (via injections), inhalation, transdermal, topical and oral routes. . Many medications such as peptide and protein, antibody, vaccine and gene based drugs, in general may not be delivered using these routes because they might be susceptible to enzymatic degradation or can not be absorbed into the systemic circulation efficiently due to molecular size and charge issues to be therapeutically effective. For this reason many protein and peptide drugs have to be delivered by injection or a nanoneedle array.
For example, many immunizations are based on the delivery of protein drugs and are often done by injection.
Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues), sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation, and methods to increase survival of peroral agents which must pass through the stomach's acidic environment. In order to achieve efficient targeted delivery, the designed system must avoid the host's defense mechanisms and circulate to its intended site of action. Types of sustained release formulations include liposomes, drug loaded biodegradable microspheres and drug polymer conjugates. Survival of agents as they pass through the stomach typically is an issue for agents which cannot be encased in a solid tablet; one research area has been around the utilization of lipid isolates from the acid-resistant archaea Sulfolobus islandicus, which confers on the order of 10% survival of liposome-encapsulated agents.

More about Drug Delivery